Overview Financials News + Filings Key Docs Charts Ownership Insiders
|
|
AZIYO BIOLOGICS, INC. (AZYO)
|
|
| Balance Sheet |
|
|
|
| Standardized | As Reported |
Annual | Quarterly |
|
| In millions, except per share items | Jun-30-23 | Mar-31-23 | Dec-31-22 | Sep-30-22 | Jun-30-22 | Mar-31-22 | Dec-31-21 | Sep-30-21 |
| | 10-Q | 10-Q | 10-K | 10-Q | 10-Q | 10-Q | 10-K | 10-Q |
| Assets |
| Cash and equivalents | 9.3 | 11.8 | 17.0 | 8.1 | 16.5 | 22.1 | 30.4 | 22.5 |
| Accounts receivable, net | 6.3 | 7.3 | 6.8 | 7.2 | 6.6 | 6.0 | 6.0 | 5.5 |
| Inventories | 9.3 | 11.1 | 10.1 | 10.2 | 9.7 | 9.9 | 9.6 | 9.8 |
| Other current assets | 11.2 | 13.3 | 16.8 | 18.2 | 1.9 | 3.1 | 1.5 | 1.4 |
| Total current assets | 36.1 | 43.5 | 50.7 | 43.7 | 34.7 | 41.1 | 47.4 | 39.3 |
| Property, plant, and equipment, net | 1.5 | 1.5 | 1.4 | 1.4 | 1.3 | 1.2 | 1.2 | 1.3 |
| Intangibles | 13.4 | 14.2 | 15.1 | 15.9 | 16.8 | 17.6 | 18.5 | 19.3 |
| Other fixed assets | 1.4 | 1.5 | 1.7 | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 |
| Total assets | 52.3 | 60.6 | 68.8 | 61.0 | 52.9 | 59.9 | 67.2 | 59.9 |
| |
| Accounts payable | 3.2 | 3.5 | 2.3 | 2.6 | 1.8 | 1.7 | 1.6 | 1.7 |
| Accrued expenses | 14.5 | 15.6 | 17.4 | 17.6 | 7.5 | 5.8 | 6.4 | 5.2 |
| Short-term debt | 0.0 | 0.0 | 0.0 | 0.0 | 8.1 | 8.1 | 8.1 | 8.1 |
| Short-term debt | | | | | 8.1 | 8.1 | 8.1 | 8.1 |
| Deferred revenues | | | | | | | | 0.1 |
| Other current liabilities | 25.2 | 22.3 | 22.9 | 19.9 | 17.4 | 11.8 | 10.0 | 7.4 |
| Total current liabilities | 42.9 | 41.4 | 42.6 | 40.2 | 34.7 | 27.3 | 26.0 | 22.5 |
| Long-term debt | 24.9 | 24.6 | 24.3 | 20.0 | 7.1 | 8.8 | 10.4 | 12.0 |
| Other liabilities | 6.7 | 6.8 | 7.0 | 11.5 | 12.4 | 17.3 | 17.2 | 17.5 |
| Total liabilities | 74.5 | 72.8 | 73.9 | 71.7 | 54.2 | 53.4 | 53.6 | 52.0 |
| |
| Shareholders' equity [+] | -22.1 | -12.2 | -5.0 | -10.7 | -1.4 | 6.6 | 13.5 | 7.9 |
| Paid-in capital | 134.4 | 133.8 | 132.9 | 121.9 | 121.3 | 119.8 | 118.6 | 103.9 |
| Retained earnings | -156.6 | -146.0 | -138.0 | -132.5 | -122.6 | -113.2 | -105.1 | -96.0 |
| Tangible shareholders' equity | -35.5 | -26.4 | -20.1 | -26.6 | -18.1 | -11.1 | -4.9 | -11.5 |
|